SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001513160-12-000030
Filing Date
2012-04-16
Accepted
2012-04-16 16:52:30
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 OXIS ANNUAL REPORT 2011 oxis10k2011.htm 10-K 1283977
2 CONSENT OF SELIGSON & GIANNATTASIO, LLP ex231.htm EX-23.1 3097
3 EXHIBIT 31.1 ex311.htm EX-31.1 9955
4 EXHIBIT 32.1 ex321.htm EX-32.1 6872
  Complete submission text file 0001513160-12-000030.txt   2957465

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxis-20111231.xml EX-101.INS 302640
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20111231.xsd EX-101.SCH 14085
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxis-20111231_cal.xml EX-101.CAL 28694
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20111231_def.xml EX-101.DEF 14741
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20111231_lab.xml EX-101.LAB 102441
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20111231_pre.xml EX-101.PRE 64996
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-08092 | Film No.: 12761685
SIC: 2834 Pharmaceutical Preparations